Jessie Hanrahan

CIK: 0001954826

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (33.3%)

Position reduction

Option Exercises (M)6 (33.3%)

Derivative conversions

Awards (A)6 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SLDB

Solid Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

SLDB
Solid Biosciences Inc.
Feb 18, 2026
Sale(S)
Direct
4.1K shares at avg. $5.82$24K
SLDB
Solid Biosciences Inc.
Feb 13, 2026
Exercise(M)
Direct
8.1K shares-
SLDB
Solid Biosciences Inc.
Feb 4, 2026
Sale(S)
Direct
12.3K shares at avg. $6.44$80K
SLDB
Solid Biosciences Inc.
Feb 2, 2026
Sale(S)
Direct
26.5K shares at avg. $6.44$171K
SLDB
Solid Biosciences Inc.
Jan 31, 2026
Exercise(M)
Direct
27.6K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
54.9K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
95K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Exercise(M)
Direct
54.9K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
190K shares-
SLDB
Solid Biosciences Inc.
Dec 3, 2025
Sale(S)
Direct
4.5K shares at avg. $5.11$23K
SLDB
Solid Biosciences Inc.
Dec 2, 2025
Exercise(M)
Direct
11.9K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Restricted Stock Units
Direct
71.3K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
142.5K shares-
SLDB
Solid Biosciences Inc.
Feb 14, 2025
Sale(S)
Direct
3.1K shares at avg. $3.96$12K
SLDB
Solid Biosciences Inc.
Feb 13, 2025
Exercise(M)
Direct
8.1K shares-
SLDB
Solid Biosciences Inc.
Jan 31, 2025
Award(A)
Restricted Stock Units
Direct
110.5K shares-
SLDB
Solid Biosciences Inc.
Dec 3, 2024
Sale(S)
Direct
4.6K shares at avg. $5.60$26K
SLDB
Solid Biosciences Inc.
Dec 2, 2024
Exercise(M)
Direct
11.9K shares-

		Type	Shares	Price		Ownership
Feb 18, 2026	SLDB Solid Biosciences Inc.	Sale(S)	4,134	$5.82	$24,074	Direct
Feb 13, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	8,125	-	$0	Direct
Feb 4, 2026	SLDB Solid Biosciences Inc.	Sale(S)	12,348	$6.44	$79,545	Direct
Feb 2, 2026	SLDB Solid Biosciences Inc.	Sale(S)	26,535	$6.44	$170,803	Direct
Jan 31, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	27,625	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	54,925	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	95,000	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	54,925	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	190,000	-	-	Direct
Dec 3, 2025	SLDB Solid Biosciences Inc.	Sale(S)	4,483	$5.11	$22,908	Direct
Dec 2, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	11,862	-	-	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	71,250	-	-	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	142,500	-	-	Direct
Feb 14, 2025	SLDB Solid Biosciences Inc.	Sale(S)	3,079	$3.96	$12,193	Direct
Feb 13, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	8,125	-	-	Direct
Jan 31, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	110,500	-	-	Direct
Dec 3, 2024	SLDB Solid Biosciences Inc.	Sale(S)	4,610	$5.60	$25,822	Direct
Dec 2, 2024	SLDB Solid Biosciences Inc.	Exercise(M)	11,862	-	$0	Direct

1-18 of 18 transactions

About Hanrahan Jessie

Hanrahan Jessie (SEC CIK 0001954826) files insider reports with the SEC as Chief Regulatory Officer of Solid Biosciences Inc. (SLDB).

Signal8 holds 9 ownership filings by Hanrahan Jessie, all Form 4s, filed between Dec 4, 2024 and Apr 21, 2026. Those filings report 18 transactions, from Dec 2, 2024 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hanrahan Jessie's filings is in CHARLESTOWN, MA.

Recent filings by Hanrahan Jessie

Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 2, 2026: Open-market sale of SLDB shares (Form 4, code S).
Jan 31, 2026: Option exercise of SLDB shares (Form 4, code M).

Other insiders filing for Solid Biosciences Inc. (SLDB)

Ganot Ilan, Director
Brooks Gabriel, Chief Medical Officer
SMITH IAN F, Director
RA CAPITAL MANAGEMENT, L.P., 10% Owner
Nagendran Sukumar, Director
PERCEPTIVE ADVISORS LLC, Director

How to read Form 4 transaction codes